PRDS - Pardes Biosciences GAAP EPS of -$10.13 March, 29 2022 04:57 PM Pardes Biosciences Inc. Pardes Biosciences press release (NASDAQ:PRDS): FY GAAP EPS of -$10.13. Pardes’ cash and cash equivalents as of December 31, 2021 was $268.7 million. For further details see: Pardes Biosciences GAAP EPS of -$10.13